Management of dyslipidemia in pediatric renal transplant recipients
Pediatr Nephrol. 2021 Jan;36(1):51-63 doi: 10.1007/s00467-019-04428-y.
Abstract
Dyslipidemia after kidney transplantation is a common complication that has historically been underappreciated, especially in pediatric recipients. It is also a major modifiable risk factor for cardiovascular disease, a top cause of morbidity and mortality of transplant patients. While most knowledge about post-transplant dyslipidemia has been generated in adults, recommendations and treatment strategies also exist for children and are presented in this review. Awareness of these applicable guidelines and approaches is required, but not sufficient, for the reliable management of dyslipidemia in our patients, and additional needs and opportunities for comprehensive care in this area (e.g., quality improvement) are outlined.
Metadata
Organisation: | Bock, Margret E. Section of Pediatric Nephrology, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA. Wall, Leslie. Clinical Nutrition Department, Children's Hospital Colorado, Aurora, CO, USA. Dobrec, Carly. Clinical Nutrition Department, Children's Hospital Colorado, Aurora, CO, USA. Chandran, Mary. Pharmacy Department, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA. Goebel, Jens. Section of Pediatric Nephrology, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA. jens.goebel@childrenscolorado.org. |
---|---|
Funding: | Funding not described |
Publication type: | Review, Guideline |
Organ: | Kidney; Heart; Various |
Language: | English |
MeSH terms: | Cardiovascular Diseases; Dyslipidemias; Humans; Kidney Transplantation; Risk Factors; Transplant Recipients; Heart Transplantation |